Since its first venture round in 1992, Cell
Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) has raised $1.4 billion,
including $743.3 million in equity and $662.1 million in debt. Since 2006, the
company has exchanged, extinguished or repurchased $232.1 million of its debt.
Selected events along with the company's financings are listed below. $M; Source:
BCIQ: BioCentury Online Intelligence; Cell Therapeutics; SEC documents
1993 October - Files IND for lisofylline
(CT-1501R)